Outcome of Different Therapeutic Interventions in Mild COVID-19 Patients in a Single OPD Clinic of West Bengal: A Retrospective study
Dr Sayak Roy, Shambo Samrat Samajdar, Santanu K Tripathi, Shatavisa Mukherjee, Kingshuk Bhattacharjee
doi:10.1101/2021.03.08.21252883
Introduction: With over 87,273,380 cases being reported and 1,899,440 deaths worldwide as of 9th January 2021, Coronavirus disease 2019 (COVID-19) has become the worst-hit pandemic till date. Every day clinicians are bombarded with many new treatment options that claim to be better than the others.
References
Ahmed, Karim, Ross, A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness, Int J Infect Dis
Ciccullo, Borghetti, Dal Verme, Neutrophil-to-lymphocyte ratio and clinical outcome in COVID-19: a report from the Italian front line, Int J Antimicrob Agents
Healthworld, COVID-19: Health Ministry issues revised home isolation guidelines
Janowitz, Gablenz, Pattinson, Famotidine use and quantitative symptom tracking for COVID-19 in non-hospitalised patients: a case series, Gut
Liu, Cao, Xu, Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro, Cell Discov
Ncid, None
Oldenburg, Doan, Azithromycin for severe COVID-19, Lancet
Roy, Journey So Far With COVID 19 -A Comprehensive Review, European Journal Of Clinical And Experimental Medicine
Roy, Mainakmukhopadhyay, Ventricular arrhythmia risk based on ethnicity in COVID-19 patients on hydroxychloroquine and azithromycin combination: Viewpoint, SN Compr Clin Med
Ruan, Yang, Wang, Jiang, Song, Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China, Intensive Care Med
Summary, Therapeutic management of patients with COVID-19
Velavan, Meyer, Mild versus severe COVID-19: Laboratory markers, Int J Infect Dis
Who, None
Wu, Liu, Yang, Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods, Acta Pharm Sin B
Zamanian, Pollack, Jr, Gentile, Outpatient inhaled nitric oxide in a patient with vasoreactive idiopathic pulmonary arterial hypertension and COVID-19 infection, Am J Respir Crit Care Med
DOI record:
{
"DOI": "10.1101/2021.03.08.21252883",
"URL": "http://dx.doi.org/10.1101/2021.03.08.21252883",
"abstract": "<jats:title>Abstract</jats:title><jats:sec><jats:title>Introduction</jats:title><jats:p>With over 87,273,380 cases being reported and 1,899,440 deaths worldwide as of 9th January 2021, Coronavirus disease 2019 (COVID-19) has become the worst-hit pandemic till date. Every day clinicians are bombarded with many new treatment options that claim to be better than the others.</jats:p></jats:sec><jats:sec><jats:title>Materials and methods</jats:title><jats:p>After screening the electronic database of COVID-19 patients retrospectively, 56 patients with mild COVID-19 infection matched the inclusion criteria and were divided into the four following groups - group having used Hydroxychloroquine (HCQ), group using doxycycline (DOX) + Ivermectin (IVR) combination, group receiving only azithromycin (AZ) and, group receiving only symptomatic treatment. The study’s primary objective was to see Clinical response of well-being (CRWB) reporting time after initiating treatment onset between the four different treatment arms.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>CRWB did not differ between the four groups receiving four different managements (p-value 0.846). There was significant correlation between blood levels of LDH (p-value 0.001), CRP (p-value 0.03) and D-dimer (p-value 0.04) with CRWB in IVR+DOX group and, between LDH (p-value 0.001), CRP (p-value 0.01) and age (p-value 0.035) with CRWB in the symptomatic management group.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>Mild COVID-19 infection in patients having low-risk to progress can be managed symptomatically without any specific drug intervention.</jats:p></jats:sec>",
"accepted": {
"date-parts": [
[
2021,
3,
22
]
]
},
"author": [
{
"ORCID": "http://orcid.org/0000-0002-6185-9375",
"affiliation": [],
"authenticated-orcid": false,
"family": "Roy",
"given": "Sayak",
"sequence": "first"
},
{
"affiliation": [],
"family": "Samajdar",
"given": "Shambo Samrat",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Tripathi",
"given": "Santanu K",
"sequence": "additional"
},
{
"ORCID": "http://orcid.org/0000-0001-9524-1525",
"affiliation": [],
"authenticated-orcid": false,
"family": "Mukherjee",
"given": "Shatavisa",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Bhattacharjee",
"given": "Kingshuk",
"sequence": "additional"
}
],
"container-title": [],
"content-domain": {
"crossmark-restriction": false,
"domain": []
},
"created": {
"date-parts": [
[
2021,
3,
12
]
],
"date-time": "2021-03-12T14:40:23Z",
"timestamp": 1615560023000
},
"deposited": {
"date-parts": [
[
2022,
12,
21
]
],
"date-time": "2022-12-21T09:03:55Z",
"timestamp": 1671613435000
},
"group-title": "Infectious Diseases (except HIV/AIDS)",
"indexed": {
"date-parts": [
[
2022,
12,
22
]
],
"date-time": "2022-12-22T05:31:07Z",
"timestamp": 1671687067555
},
"institution": [
{
"name": "medRxiv"
}
],
"is-referenced-by-count": 1,
"issued": {
"date-parts": [
[
2021,
3,
12
]
]
},
"link": [
{
"URL": "https://syndication.highwire.org/content/doi/10.1101/2021.03.08.21252883",
"content-type": "unspecified",
"content-version": "vor",
"intended-application": "similarity-checking"
}
],
"member": "246",
"original-title": [],
"posted": {
"date-parts": [
[
2021,
3,
12
]
]
},
"prefix": "10.1101",
"published": {
"date-parts": [
[
2021,
3,
12
]
]
},
"publisher": "Cold Spring Harbor Laboratory",
"reference": [
{
"key": "2021032410001188000_2021.03.08.21252883v2.1",
"unstructured": "Who.int. Accessed January 16, 2021. https://covid19.who.int/."
},
{
"key": "2021032410001188000_2021.03.08.21252883v2.2",
"unstructured": "Executive Summary. Therapeutic management of patients with COVID-19. Nih.gov. Accessed January 16, 2021. https://files.covid19treatmentguidelines.nih.gov/guidelines/section/section_100.pdf"
},
{
"key": "2021032410001188000_2021.03.08.21252883v2.3",
"unstructured": "Gov.in. Accessed January 16, 2021. https://www.wbhealth.gov.in/uploaded_files/corona/WB_Covid_protocol_book_25.09_.20_(1)_.pdf"
},
{
"key": "2021032410001188000_2021.03.08.21252883v2.4",
"unstructured": "HealthWorld ET. COVID-19: Health Ministry issues revised home isolation guidelines. PTI. Published July 3, 2020. Accessed January 16, 2021. https://health.economictimes.indiatimes.com/news/policy/covid-19-health-ministry-issues-revised-home-isolation-guidelines/76767874"
},
{
"key": "2021032410001188000_2021.03.08.21252883v2.5",
"unstructured": "Clinical management of COVID-19. Who.int. Accessed January 16, 2021. https://www.who.int/publications/i/item/clinical-management-of-covid-19"
},
{
"DOI": "10.1136/gutjnl-2020-321852",
"doi-asserted-by": "publisher",
"key": "2021032410001188000_2021.03.08.21252883v2.6"
},
{
"article-title": "A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness",
"first-page": "214",
"journal-title": "Int J Infect Dis",
"key": "2021032410001188000_2021.03.08.21252883v2.7",
"volume": "103",
"year": "2020"
},
{
"DOI": "10.1164/rccm.202004-0937LE",
"article-title": "Outpatient inhaled nitric oxide in a patient with vasoreactive idiopathic pulmonary arterial hypertension and COVID-19 infection",
"doi-asserted-by": "crossref",
"first-page": "130",
"issue": "1",
"journal-title": "Am J Respir Crit Care Med",
"key": "2021032410001188000_2021.03.08.21252883v2.8",
"volume": "202",
"year": "2020"
},
{
"DOI": "10.1016/j.apsb.2020.02.008",
"article-title": "Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods",
"doi-asserted-by": "crossref",
"first-page": "766",
"issue": "5",
"journal-title": "Acta Pharm Sin B",
"key": "2021032410001188000_2021.03.08.21252883v2.9",
"volume": "10",
"year": "2020"
},
{
"article-title": "MainakMukhopadhyay. Ventricular arrhythmia risk based on ethnicity in COVID-19 patients on hydroxychloroquine and azithromycin combination: Viewpoint",
"first-page": "1",
"issue": "8",
"journal-title": "SN Compr Clin Med",
"key": "2021032410001188000_2021.03.08.21252883v2.10",
"volume": "2",
"year": "2020"
},
{
"DOI": "10.1016/S0140-6736(20)31863-8",
"article-title": "Azithromycin for severe COVID-19",
"doi-asserted-by": "crossref",
"first-page": "936",
"issue": "10256",
"journal-title": "Lancet",
"key": "2021032410001188000_2021.03.08.21252883v2.11",
"volume": "396",
"year": "2020"
},
{
"DOI": "10.1038/s41421-020-0156-0",
"doi-asserted-by": "publisher",
"key": "2021032410001188000_2021.03.08.21252883v2.12"
},
{
"key": "2021032410001188000_2021.03.08.21252883v2.13",
"unstructured": "Ncid.sg. Accessed January 16, 2021. https://www.ncid.sg/Health-Professionals/Diseases-and-Conditions/Documents/Treatment%20Guidelines%20for%20COVID-19%20%282%20Apr%202020%29%20-final.pdf"
},
{
"key": "2021032410001188000_2021.03.08.21252883v2.14",
"unstructured": "Therapeutic Management. Nih.gov. Accessed January 16, 2021. https://www.covid19treatmentguidelines.nih.gov/therapeutic-management/"
},
{
"DOI": "10.15584/ejcem.2020.4.7",
"doi-asserted-by": "crossref",
"key": "2021032410001188000_2021.03.08.21252883v2.15",
"unstructured": "Roy, S. , 2020. Journey So Far With COVID 19 – A Comprehensive Review | European Journal Of Clinical And Experimental Medicine. [online] Ejcem.ur.edu.pl. Available at: <http://www.ejcem.ur.edu.pl/summary/journey-so-far-covid-19-comprehensive-review> [accessed 17 January 2021]. http://www.ejcem.ur.edu.pl/summary/journey-so-far-covid-19-comprehensive-review"
},
{
"key": "2021032410001188000_2021.03.08.21252883v2.16",
"unstructured": "Prophylactic Ivermectin in COVID-19 Contacts. Clinicaltrials.gov. Accessed January 16, 2021. https://clinicaltrials.gov/ct2/show/results/NCT04422561."
},
{
"key": "2021032410001188000_2021.03.08.21252883v2.17",
"unstructured": "USEFULNESS of Topic Ivermectin and Carrageenan to Prevent Contagion of Covid 19 - Study Results - ClinicalTrials.Gov. Clinicaltrials.gov. Accessed January 16, 2021. https://clinicaltrials.gov/ct2/show/results/NCT04425850."
},
{
"DOI": "10.1016/j.ijantimicag.2020.106017",
"article-title": "Neutrophil-to-lymphocyte ratio and clinical outcome in COVID-19: a report from the Italian front line",
"doi-asserted-by": "crossref",
"first-page": "106017",
"issue": "2",
"journal-title": "Int J Antimicrob Agents",
"key": "2021032410001188000_2021.03.08.21252883v2.18",
"volume": "56",
"year": "2020"
},
{
"DOI": "10.1016/j.ijid.2020.04.061",
"doi-asserted-by": "publisher",
"key": "2021032410001188000_2021.03.08.21252883v2.19"
},
{
"DOI": "10.1007/s00134-020-05991-x",
"doi-asserted-by": "publisher",
"key": "2021032410001188000_2021.03.08.21252883v2.20"
}
],
"reference-count": 20,
"references-count": 20,
"relation": {},
"resource": {
"primary": {
"URL": "http://medrxiv.org/lookup/doi/10.1101/2021.03.08.21252883"
}
},
"score": 1,
"short-title": [],
"source": "Crossref",
"subtitle": [],
"subtype": "preprint",
"title": "Outcome of Different Therapeutic Interventions in Mild COVID-19 Patients in a Single OPD Clinic of West Bengal: A Retrospective study",
"type": "posted-content"
}
